Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released May 2, 2019, after the close
10-Q filed May 8, 2019, 38 days after period end · 0001171843-19-003099
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Revenue | $28.20M | $26.76M | $18.09M | $26.96M |
| Net Income | -$2.37M | -$4.06M | -$1.07M | -$636.00K |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.06 |
| -$0.11 |
| -$0.03 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
